- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on HRD
Total 191 results
-
Astellas Pharma Global Development, Inc.No longer availableAcute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) MutationsAustralia, Italy, United Kingdom
-
Mansoura UniversityCompletedResponse Assessment in Newly Diagnosed RA Patients at 3rd Month Was Evaluated by DAS28 and ACR in Relation to JAK ExpressionEgypt
-
Novartis PharmaceuticalsRecruiting
-
Beijing 302 HospitalNot yet recruitingHR+/HER2- Advanced Breast CancerChina
-
Fudan UniversityNot yet recruiting
-
Hunan Cancer HospitalRecruiting
-
Children's Hospital of PhiladelphiaBaylor College of Medicine; Children's Hospital Colorado; Seattle Children's... and other collaboratorsRecruitingHypoxia | Intubation Complication | Intubation; Difficult or Failed | Hypoxemia | Anesthesia Intubation Complication | Pediatric HDUnited States
-
Jazz PharmaceuticalsActive, not recruitingHER2+/HR+ Breast CancerUnited States, Spain, Canada
-
Centre Hospitalier Universitaire, AmiensRecruitingEpilepsy | Children | tDCS | Transcranial Electric Stimulation | Pharmacoresistant | HR EEGFrance
-
Novartis PharmaceuticalsNo longer availableHR+ Advanced or Metastatic Breast Cancer
-
Khon Kaen UniversityCompleteda Single-Dose of Etoricoxib | Post-Operative Morphine Consumption | Total Pain Relief Over 8 Hr(TOPAR8) | Post Transabdominal HysterectomyThailand
-
Tianjin Medical University Cancer Institute and...Not yet recruitingAdvanced HR+ HER2 Negative Breast Carcinoma
-
Tianjin Medical University Cancer Institute and...RecruitingAdvanced HR+ HER2 Negative Breast CarcinomaChina
-
Novartis PharmaceuticalsAvailableHR+, HER2-, Advanced Breast Cancer
-
Henan Cancer HospitalRecruitingHR Positive HER2 Negative Advanced Breast CancerChina
-
PfizerCompletedHR+/HER2- Locally Advanced, Metastatic Breast CancerUnited Kingdom
-
Nanjing Chia-tai Tianqing PharmaceuticalRecruitingHR Positive/HER-2 Negative Breast CancerChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingHR-positive, HER2-negative Advanced Breast CancerChina
-
GlycoMimetics IncorporatedTerminatedBreast Cancer | Breast Cancer Metastatic | HR+ Metastatic Breast CancerUnited States
-
Novartis PharmaceuticalsNo longer availableAdvanced Hormone Receptor Positive (HR+) Breast Cancer
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingHR-positive,HER2-negative in Advanced Breast CancerChina
-
Shanghai General Hospital, Shanghai Jiao Tong University...CompletedAcute Lymphoblastic Leukemia | MRD-positiveChina
-
Capital Medical UniversityRecruitingHad a Computed Tomography Scan of the Chest Within 24 Hours After Stroke OnsetChina
-
Centre Hospitalier Universitaire DijonCompletedPatient With Symptomatic Cerebral Infarction | Patient Who Has Had a Mechanical ThrombectomyFrance
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Recruiting
-
Henan Cancer HospitalNot yet recruitingAdvanced Breast Cancer | Treatment | HR Low/HER2 Negative
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Not yet recruitingHR+/HER2- Advanced and/or Metastatic Breast Cancer
-
French Innovative Leukemia OrganisationAbbVie; Janssen-Cilag Ltd.Active, not recruitingIntermediate Risk Chronic Lymphocytic Leukemia | Fit Patients | Risk-Adapted and MRD-Driven StrategyFrance
-
TRPHARMFennec PharmaAvailableCisplatin-Induced Hearing Loss in Children Who Had Standard-risk HepatoblastomaTurkey
-
Rambam Health Care CampusUnknownA Known Allergy to Antiseptic Soap | Women Who Had Any Infection in the Perioperative Period | A Known Allergy to Chlorohexidine Alcohol or Shellfis
-
Seoul National University HospitalCompletedPatients Who Had the Urine Volume at Nighttime More Than One Third of Total Daily Urine Volume (NPU) and Voided More Than Two Times at Nighttime (Nocturia)Korea, Republic of
-
Cancer Institute and Hospital, Chinese Academy...RecruitingTargeted Therapy | HR+/HER2- Advanced Breast CancerChina
-
Tianjin Medical University Cancer Institute and...RecruitingHR Positive HER2 Negative Advanced Breast CancerChina
-
Beta Pharma (Suzhou) Co., Ltd.RecruitingAdvanced Solid Tumor | HR+/HER2- Breast CancerChina
-
Novartis PharmaceuticalsCompletedHR+/HER2- Advanced or Metastatic Breast CancerIreland
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHR Positive/HER2 Low Expression Metastatic Breast CancerChina
-
Novartis PharmaceuticalsCompletedHR+ HER2- Men, Pre/Postmenopausal Advanced Breast CancerCanada
-
M.D. Anderson Cancer CenterPfizerNot yet recruitingMultiple Myeloma | Post-transplant MRD-guided Maintenance Therapy | Pre-transplant PurgingUnited States
-
Boston Medical CenterCompleted
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownHR-positive, HER2-negative and PIK3CA Mutation Advanced Breast CancerChina
-
Assistance Publique - Hôpitaux de ParisUnknownBreast Cancer | Metastasis | HR+/HER2-negative Breast Cancer
-
Fudan UniversityNot yet recruitingNeoadjuvant Therapy | Early Breast Cancer | HR+HER2- Breast Cancer
-
AmgenRecruitingB-precursor Acute Lymphoblastic LeukemiaUnited States
-
Centre Hospitalier René DubosCompletedImpact of Antenatal Corticosteroid Therapy on Postnatal Surfactant Use in Preterm Infants (CORISURF)Hyaline Membrane Disease (HMD)France
-
Istituto Oncologico Veneto IRCCSAssociation for Translational Research in Oncology (AS.T.R.O.)CompletedEndocrine Sensitive HER2+/HR+ Breast CancerItaly
-
H. Lee Moffitt Cancer Center and Research InstituteKite, A Gilead CompanyRecruitingAcute Lymphoblastic Leukemia | B-Cell Lymphoblastic LeukemiaUnited States
-
Samsung Medical CenterNot yet recruitingPremenopausal HR+/HER2- Metastatic Breast CancerKorea, Republic of
-
University of Michigan Rogel Cancer CenterJanssen Scientific Affairs, LLCActive, not recruiting
-
Biocon Biologics UK LtdNot yet recruitingHR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
-
UNICANCERARCAGY/ GINECO GROUP; SOLTI Breast Cancer Research GroupActive, not recruitingER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer | a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI StatusFrance